Skip to main content
Clinical Trials/JPRN-UMIN000027219
JPRN-UMIN000027219
Completed
Phase 2

Phase II trial of Transcatheter arterial micro-embolization for refractory chronic hip pain: Multicenter Study (REACH study) - hip TAME: JMIS-1603 (REACH study)

Miyakojima IGRT clinic0 sites20 target enrollmentMay 2, 2017

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Chronic hip pain refractory to non-surgical management due to mild osteoarthritis
Sponsor
Miyakojima IGRT clinic
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 2, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Miyakojima IGRT clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Surgical candidate 2\.Patients with severe infection, rheumatoid arthritis, or mental disorder 3\.Patients with uncontrollable diabetic mellitus 4\.Pain due to spine pathology 5\.Patients with osteonecrosis with magnetic resonance imaging (MRI) 6\.Patients without possibility of going to hospital and follow up for 6 months. 7\.Patient who was decided not to be appropriate for this trial by physician

Outcomes

Primary Outcomes

Not specified

Similar Trials